Often, despite early success with standard chemotherapy and radiotherapy, LS-SCLC often comes back with only about 15% to 30% of people surviving ... under the brand name Imfinzi, is a human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback